Paper2760041
Characterization of two distinct positive cis-acting elements in the mouse alpha 1 (III) collagen promoter.
Ruteshouser EC and 1 other. J Biol Chem, 1989. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Characterization of two distinct positive cis-acting elements in the mouse alpha 1 (III) collagen promoter. Papers, record 2760041. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2760041
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Collagen | Major topic |
| Genes | Major topic |
| Promoter Regions, Genetic | Major topic |
| Regulatory Sequences, Nucleic Acid | Major topic |
| Animals | |
| Base Sequence | |
| Mice | |
| Molecular Sequence Data | |
| Mutation | |
| Plasmids | |
| Restriction Mapping |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-09299 | NCI NIH HHS | United States | T32CA009299 | PubMed and NIH | NIH RePORTER |
| CA-16672 | NCI NIH HHS | United States | P01CA016672 | PubMed and NIH | NIH RePORTER |
| P30CA016672 | NIH | NIH RePORTER |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32160132 | PTH/PTHrP Receptor Signaling Restricts Arterial Fibrosis in Diabetic LDLR-/- Mice by Inhibiting Myocardin-Related Transcription Factor Relays. | Circ Res | 2020 | https://conductscience.org/library/papers/32160132 | PubMed |
| 20558820 | Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. | Circ Res | 2010 | https://conductscience.org/library/papers/20558820 | PubMed |
| 9241239 | Cell-specific in vivo DNA-protein interactions at the proximal promoters of the pro alpha 1(I) and the pro alpha2(I) collagen genes. | Nucleic Acids Res | 1997 | https://conductscience.org/library/papers/9241239 | PubMed |
| 9171101 | The chick type III collagen gene contains two promoters that are preferentially expressed in different cell types and are separated by over 20 kb of DNA containing 23 exons. | Nucleic Acids Res | 1997 | https://conductscience.org/library/papers/9171101 | PubMed |
| 8920984 | The transcription of human alpha 1(I) procollagen gene (COL1A1) is suppressed by tumour necrosis factor-alpha through proximal short promoter elements: evidence for suppression mechanisms mediated by two nuclear-factorbinding sites. | Biochem J | 1996 | https://conductscience.org/library/papers/8920984 | PubMed |
| 8774909 | Evidence for three major transcription activation elements in the proximal mouse proalpha2(I) collagen promoter. | Nucleic Acids Res | 1996 | https://conductscience.org/library/papers/8774909 | PubMed |
| 1820205 | Homology between alpha 2(V) and alpha 1(III) collagen promoters and evidence for negatively acting elements in the alpha 2(V) first intron and 5' flanking sequences. | Gene Expr | 1991 | https://conductscience.org/library/papers/1820205 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2760041
GET https://conductscience.org/api/papers/v1/2760041/authors